JP2024526282A5 - - Google Patents
Info
- Publication number
- JP2024526282A5 JP2024526282A5 JP2023581076A JP2023581076A JP2024526282A5 JP 2024526282 A5 JP2024526282 A5 JP 2024526282A5 JP 2023581076 A JP2023581076 A JP 2023581076A JP 2023581076 A JP2023581076 A JP 2023581076A JP 2024526282 A5 JP2024526282 A5 JP 2024526282A5
- Authority
- JP
- Japan
- Prior art keywords
- physiologically acceptable
- marxianus
- composition according
- boulardii
- saccharomyces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382576.3 | 2021-06-30 | ||
| EP21382576 | 2021-06-30 | ||
| EP22382114 | 2022-02-11 | ||
| EP22382114.1 | 2022-02-11 | ||
| PCT/EP2022/068192 WO2023275323A1 (en) | 2021-06-30 | 2022-06-30 | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526282A JP2024526282A (ja) | 2024-07-17 |
| JP2024526282A5 true JP2024526282A5 (cg-RX-API-DMAC7.html) | 2025-06-30 |
Family
ID=82308337
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581073A Pending JP2024524501A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
| JP2023581076A Pending JP2024526282A (ja) | 2021-06-30 | 2022-06-30 | 胃腸疾患の処置において使用する為の生理学的に許容される酵母組成物 |
| JP2023581075A Withdrawn JP2024524502A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581073A Pending JP2024524501A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581075A Withdrawn JP2024524502A (ja) | 2021-06-30 | 2022-06-30 | 生理学的に許容される酵母組成物及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240316131A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4362710A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2024524501A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20240037257A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2022302361A1 (cg-RX-API-DMAC7.html) |
| CA (3) | CA3223134A1 (cg-RX-API-DMAC7.html) |
| CO (3) | CO2024000322A2 (cg-RX-API-DMAC7.html) |
| IL (3) | IL309525A (cg-RX-API-DMAC7.html) |
| MX (3) | MX2023015507A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2023275325A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
| WO2025104171A1 (en) * | 2023-11-14 | 2025-05-22 | Ab Mauri (Uk) Ltd | Physiologically acceptable microbiological compositions comprising lactic acid bacteria and kluyveromyces marxianus yeast and uses thereof |
| CN117866854B (zh) * | 2024-03-08 | 2024-06-07 | 广州同康生物科技有限公司 | 修复胃肠黏膜损伤的罗伊氏粘液乳杆菌bn01及其后生元 |
| WO2025233827A1 (en) * | 2024-05-10 | 2025-11-13 | A. Menarini International Licensing S.A. | Beneficial complementary symbiotic and mineral mix |
| EP4732843A1 (en) * | 2024-10-22 | 2026-04-29 | Lesaffre et Compagnie | Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101654537B1 (ko) | 2007-12-26 | 2016-09-06 | 르샤프르 에 꽁빠니 | 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균 |
| EA202090769A1 (ru) * | 2018-05-04 | 2020-06-11 | Борис Славинович ФАРБЕР | Пищевая, косметическая и фармацевтическая композиция с иммуномодулирующим и протективным антивирусным эффектом |
| CN111944725B (zh) * | 2020-08-24 | 2021-12-07 | 汤臣倍健股份有限公司 | 一种副干酪乳杆菌207-27及其应用 |
| CA3223134A1 (en) * | 2021-06-30 | 2023-01-05 | Carlos DE LECEA | Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder |
-
2022
- 2022-06-30 CA CA3223134A patent/CA3223134A1/en active Pending
- 2022-06-30 JP JP2023581073A patent/JP2024524501A/ja active Pending
- 2022-06-30 AU AU2022302361A patent/AU2022302361A1/en active Pending
- 2022-06-30 AU AU2022303105A patent/AU2022303105A1/en active Pending
- 2022-06-30 IL IL309525A patent/IL309525A/en unknown
- 2022-06-30 MX MX2023015507A patent/MX2023015507A/es unknown
- 2022-06-30 KR KR1020247003284A patent/KR20240037257A/ko active Pending
- 2022-06-30 WO PCT/EP2022/068197 patent/WO2023275325A1/en not_active Ceased
- 2022-06-30 MX MX2023015498A patent/MX2023015498A/es unknown
- 2022-06-30 KR KR1020247003278A patent/KR20240037981A/ko active Pending
- 2022-06-30 AU AU2022303106A patent/AU2022303106A1/en active Pending
- 2022-06-30 CA CA3223303A patent/CA3223303A1/en active Pending
- 2022-06-30 JP JP2023581076A patent/JP2024526282A/ja active Pending
- 2022-06-30 KR KR1020247003283A patent/KR20240037256A/ko active Pending
- 2022-06-30 MX MX2023015516A patent/MX2023015516A/es unknown
- 2022-06-30 US US18/575,600 patent/US20240316131A1/en active Pending
- 2022-06-30 EP EP22735002.2A patent/EP4362710A1/en active Pending
- 2022-06-30 WO PCT/EP2022/068151 patent/WO2023275293A1/en not_active Ceased
- 2022-06-30 WO PCT/EP2022/068192 patent/WO2023275323A1/en not_active Ceased
- 2022-06-30 EP EP22735003.0A patent/EP4362711A1/en active Pending
- 2022-06-30 CA CA3223136A patent/CA3223136A1/en active Pending
- 2022-06-30 JP JP2023581075A patent/JP2024524502A/ja not_active Withdrawn
- 2022-06-30 EP EP22735004.8A patent/EP4362712A1/en active Pending
- 2022-06-30 US US18/575,677 patent/US20240325475A1/en active Pending
- 2022-06-30 US US18/575,656 patent/US20240293488A1/en active Pending
- 2022-06-30 IL IL309519A patent/IL309519A/en unknown
- 2022-06-30 IL IL309521A patent/IL309521A/en unknown
-
2024
- 2024-01-16 CO CONC2024/0000322A patent/CO2024000322A2/es unknown
- 2024-01-16 CO CONC2024/0000323A patent/CO2024000323A2/es unknown
- 2024-01-16 CO CONC2024/0000344A patent/CO2024000344A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024526282A5 (cg-RX-API-DMAC7.html) | ||
| AU2004267304B2 (en) | Lactic acid bacteria having mucosal immunopotentiation effect | |
| CN1767839B (zh) | 抗过敏的组合物 | |
| IL309525A (en) | Physiologically adjusted yeast preparations for use as a treatment for digestive system disease | |
| JP4942831B2 (ja) | 抗アレルギー用組成物 | |
| US20150238547A1 (en) | Lactic acid bacterium-containing preparation | |
| JP2024524502A5 (cg-RX-API-DMAC7.html) | ||
| JP2024524501A5 (cg-RX-API-DMAC7.html) | ||
| JP2011509651A5 (cg-RX-API-DMAC7.html) | ||
| KR20190128087A (ko) | 소화 건강, 체중 조절, 면역 강화 및 건강 개선을 위한 다중섬유 프리바이오틱 제제 | |
| JP2023502708A (ja) | ビフィドバクテリウム・ラクティスｂｌ－９９の腸管炎症の抑制における新規な用途 | |
| CN106795482B (zh) | 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物 | |
| Amrouche et al. | Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19 | |
| JP2023516268A (ja) | ラクトバチルス・ヘルベティカス株及びそれを含む炎症性疾患を予防又は処置するための組成物 | |
| CN104611278A (zh) | 一种能够缓解铝毒性的植物乳杆菌及其用途 | |
| WO2006093267A1 (ja) | 免疫調節作用を有する発酵組成物 | |
| CN118354680A (zh) | 用于治疗胃肠障碍的生理学上可接受的酵母菌组合物 | |
| EP2696880A1 (en) | Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny | |
| CN100564511C (zh) | 具有免疫调节作用的组合物 | |
| WO2015046407A1 (ja) | 免疫疾患予防剤 | |
| Savitri et al. | Probiotics for human health | |
| Savadogo et al. | Probiotic microorganisms involved in cassava fermentation for Garia and Attiéké production | |
| JP7348187B2 (ja) | 腸内環境改善用組成物及び腸内細菌叢改善方法 | |
| CN102388971A (zh) | 一种复方牛初乳粉 | |
| JP7803679B2 (ja) | 茶葉由来のラクチプランチバチルス・プランタラム属の新規株 |